Medicare
Gilead agrees to pay $97 million to settle Medicare kickbacks case
September 24, 2020Business Services Gilead, Medicare, drugs, kickbacks
Gilead has agreed to pay $97 million to resolve claims from the US Government that it used an independent charity …
Pfizer sues US for permission to help Medicare patients with rare heart conditions
June 29, 2020Sales and Marketing Medicaid, Medicare, Pfizer
Pfizer has filed a lawsuit against the US government to allow it to directly help with the copayments of Medicare …
Sanofi set to pay $11.9 million to resolve kickback probe, US Justice Department announces
March 2, 2020Sales and Marketing Co pays, Justice department, Medicaid, Medicare, Sanofi, insurance
The Justice Department have announced that Sanofi SA have agreed to pay $11.85 million to resolve allegations it used a …
Top Ten most popular articles on Pharmafile.com this week!
August 16, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Air pollution, CAR-T therapy, HIV, Kymriah, Medicare, Novartis, Yescarta, Zolgensma
Novartis’ faulty data scandal dominated the headlines this week, as the Swiss firm faced fierce backlash over covering up the …
Top Ten most popular articles on Pharmafile.com this week!
August 9, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, CAR T, CAR-T, Eli Lilly, Lexicon, Medicare, Novartis, Pfizer, Sanofi, pharma
This week’s top story covered the scandal surrounding Novartis over its covering up of faulty data from the FDA. The …
Medicare will cover CAR-T therapies in United States
August 8, 2019Sales and Marketing CAR-T therapies, Cancer, Gilead, Kymriah, Medicare, Novartis, keytruda, pharma
Medicare will cover the cost of Novartis’ and Gilead’s CAR-T therapies Kymriah and Yescarta, the US Centers for Medicare and …
Mallinckrodt illegally inflated price of drug from $50 to $32,000, DoJ lawsuit says
June 7, 2019Business Services Achthar, DoJ, Mallinckrodt, Medicare, co-pay, pharma
The Department of Justice (DoJ) has filed new charges against Mallinckrodt alleging the Irish-listed firm illegally hiked the price of …
Top Ten most popular articles on Pharmafile.com this week
August 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Eisai, Medicare, Novartis, UK, brexit, generics, king bio, pharma, top ten
Eight months of 2018 down – where has the year gone? As we move from August into September, and a …
Generics could save US Medicare $1 billion per year
August 24, 2018Medical Communications Medicare, United States, branded, generics, marketing, savings
The United States national health insurance programme Medicare could have save $1 billion through the use of generic drugs according …
No ‘Plan B’ for Obamacare
June 18, 2015Medical Communications, Sales and Marketing ACT, Medicaid, Medicare, Obama, Obamacare, patient protection
US president Barack Obama has no ‘Plan B’ if a crucial Supreme Court vote in the next fortnight goes against …
US focus: still top of the pharma pile
June 16, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medicare, Obama, Sunshine Act, US, United States, america, report
Population: 313.9 million (2012) Government: Federal presidential republic Leader: President Barack Obama of the liberal Democratic Party Gross Domestic Product: …
Obamacare: health reform’s tough start
November 1, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Medicare, Obama, Obamacare, US, affordable care act
On Tuesday 1 October, three years after it was passed, the Patient Protection and Affordable Care Act came into force …
US shutdown starts to bite – UPDATED
October 2, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDC, FDA, Medicare, Obama, Obamacare
Twenty-four hours into the US government’s shutdown, the impact on pharma of the freezing of federal government activity remains hard …
Pharma critical of Obama budget
February 15, 2012Research and Development, Sales and Marketing IPAB, Independent Payment Advisory Board, Medicare, Obama, PhRMA, US, healthcare reform
President Obama has unveiled a new budget which aims to cut the US deficit by $4 trillion over the next …
Pharma agrees cost-saving deal with US government
June 24, 2009Sales and Marketing Medicare, US, US healthcare, healthcare
Drug makers have agreed with the US government to spend $80 billion over the next ten years in a bid …
